NASDAQ:NH NantHealth - NH Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NantHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $3.06 -0.07 (-2.24%) (As of 01/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$3.06▼$3.2050-Day Range$0.19▼$5.7052-Week Range$1.57▼$15.75Volume3,615 shsAverage Volume27,930 shsMarket Capitalization$23.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability NantHealth MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy2.22% of Float Sold ShortDividend StrengthN/ASustainability-0.69Upright™ Environmental ScoreNews Sentiment0.43Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.84 out of 5 starsMedical Sector816th out of 1,055 stocksData Processing & Preparation Industry56th out of 72 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for NantHealth. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.22% of the float of NantHealth has been sold short.Short Interest Ratio / Days to CoverNantHealth has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NantHealth has recently decreased by 29.13%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldNantHealth does not currently pay a dividend.Dividend GrowthNantHealth does not have a long track record of dividend growth. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreNantHealth has received a 64.10% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Private health advocacy services", "Computerized clinical decision support software", and "Patient flow management systems" products. See details.Environmental SustainabilityThe Environmental Impact score for NantHealth is -0.69. Previous Next 1.9 News and Social Media Coverage News SentimentNantHealth has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for NantHealth this week, compared to 1 article on an average week.MarketBeat FollowsOnly 2 people have added NantHealth to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NantHealth insiders have not sold or bought any company stock.Percentage Held by Insiders61.30% of the stock of NantHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 4.50% of the stock of NantHealth is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of NantHealth is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NantHealth is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About NantHealth (NASDAQ:NH) StockNantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Morrisville, NC.Read More Receive NH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address NH Stock News HeadlinesJanuary 28, 2023 | americanbankingnews.comHead to Head Contrast: D-Wave Quantum (NYSE:QBTS) vs. NantHealth (NASDAQ:NH)January 26, 2023 | americanbankingnews.comNantHealth (NASDAQ:NH) Coverage Initiated at StockNews.comJanuary 28, 2023 | Porter & Company (Ad)The Next Big Crisis Is HereYou just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.January 16, 2023 | finance.yahoo.comNantHealth, Inc. (NH) Stock Historical Prices & Data - Yahoo FinanceDecember 15, 2022 | finance.yahoo.comNantHealth Announces 1-for-15 Reverse Stock SplitNovember 9, 2022 | finance.yahoo.comNantHealth Third Quarter 2022 Earnings: US$0.12 loss per share (vs US$0.094 loss in 3Q 2021)November 4, 2022 | finance.yahoo.comNantHealth Reports 2022 Third Quarter Financial ResultsNovember 1, 2022 | finance.yahoo.comNantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3January 28, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…October 16, 2022 | fool.comNantHealth, Inc. (NASDAQ: NH)October 11, 2022 | finance.yahoo.comWellStack Expands Executive Team with Chief Revenue Officer Christopher Rogowski - Yahoo FinanceOctober 5, 2022 | benzinga.com11 Health Care Stocks Moving In Wednesday's Pre-Market Session - Applied DNA Sciences (NASDAQ:APDN), Aven - BenzingaSeptember 27, 2022 | globenewswire.comGlobal Respiratory Care Devices Market expanding at a high-value CAGR of 8.3% by the end of 2032 - GlobeNewswireSeptember 9, 2022 | uk.investing.comWhy ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday By Benzinga - Investing.com UKSeptember 5, 2022 | bizjournals.comBillionaire's Morrisville firm tries to forestall stock delisting from the NasdaqAugust 24, 2022 | businesswire.comNantHealth's Eviti Platform Once More Earns Full URAC Accreditation Through 2025 - Business WireAugust 24, 2022 | finance.yahoo.comNantHealth’s Eviti Platform Once More Earns Full URAC Accreditation Through 2025August 12, 2022 | finance.yahoo.comSarah Chavarria Named President of Delta Dental of California and Affiliates - Yahoo FinanceAugust 5, 2022 | fool.comNantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript - The Motley FoolAugust 5, 2022 | finance.yahoo.comNantHealth, Inc. (NH) Q2 2022 Earnings Call TranscriptAugust 4, 2022 | businesswire.comNantHealth Reports 2022 Second Quarter Financial Results - Business WireAugust 4, 2022 | finance.yahoo.comNantHealth Reports 2022 Second Quarter Financial ResultsAugust 1, 2022 | finance.yahoo.comNantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4 - Yahoo FinanceAugust 1, 2022 | businesswire.comNantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4 - Business WireAugust 1, 2022 | finance.yahoo.comNantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4July 12, 2022 | streetinsider.comXealth Expands Leadership Team with Appointments of Joe Sedlak, RN, and Laurance Stuntz - StreetInsider.comJuly 8, 2022 | finance.yahoo.comNantHealth (NASDAQ:NH) investors are sitting on a loss of 90% if they invested five years agoSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive NH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address NH Company Calendar Last Earnings11/03/2022Today1/28/2023Next Earnings (Estimated)2/23/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Data processing & preparation Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NH Previous SymbolNYSE:NH CUSIPN/A CIK1566469 Webwww.nanthealth.com Phone(310) 883-1300FaxN/AEmployees326Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($7.6462) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-58,260,000.00 Net Margins-89.76% Pretax Margin-89.67% Return on EquityN/A Return on Assets-30.69% Debt Debt-to-Equity RatioN/A Current Ratio0.36 Quick Ratio0.36 Sales & Book Value Annual Sales$62.65 million Price / Sales0.38 Cash FlowN/A Price / Cash FlowN/A Book Value($21.04) per share Price / Book-0.15Miscellaneous Outstanding Shares7,710,000Free Float2,983,000Market Cap$23.59 million OptionableOptionable Beta1.96 Key ExecutivesPatrick Soon-ShiongChairman & Chief Executive OfficerRonald Allen LouksChief Operating OfficerBob PetrouChief Financial OfficerTiffany AveryChief Medical OfficerBrandon VillerySecretary, Senior VP-Legal, VP & General CounselKey CompetitorsAkernaNASDAQ:KERNVincerx PharmaNASDAQ:VINCAprea TherapeuticsNASDAQ:APREIdera PharmaceuticalsNASDAQ:IDRACyclerion TherapeuticsNASDAQ:CYCNView All Competitors NH Stock - Frequently Asked Questions How have NH shares performed in 2023? NantHealth's stock was trading at $3.65 at the beginning of 2023. Since then, NH shares have decreased by 16.2% and is now trading at $3.06. View the best growth stocks for 2023 here. Are investors shorting NantHealth? NantHealth saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 56,200 shares, a decline of 29.1% from the December 31st total of 79,300 shares. Based on an average trading volume of 100,500 shares, the short-interest ratio is presently 0.6 days. Currently, 2.2% of the shares of the company are sold short. View NantHealth's Short Interest. When is NantHealth's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023. View our NH earnings forecast. How were NantHealth's earnings last quarter? NantHealth, Inc. (NASDAQ:NH) announced its earnings results on Thursday, November, 3rd. The company reported ($0.13) EPS for the quarter. The firm had revenue of $16.63 million for the quarter. What is Patrick Soon-Shiong's approval rating as NantHealth's CEO? 82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of NantHealth own? Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX). When did NantHealth IPO? (NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers. What is NantHealth's stock symbol? NantHealth trades on the NASDAQ under the ticker symbol "NH." How do I buy shares of NantHealth? Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is NantHealth's stock price today? One share of NH stock can currently be purchased for approximately $3.06. How much money does NantHealth make? NantHealth (NASDAQ:NH) has a market capitalization of $23.59 million and generates $62.65 million in revenue each year. The company earns $-58,260,000.00 in net income (profit) each year or ($7.6462) on an earnings per share basis. How many employees does NantHealth have? The company employs 326 workers across the globe. How can I contact NantHealth? NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The official website for the company is www.nanthealth.com. The company can be reached via phone at (310) 883-1300 or via email at ir@nanthealth.com. This page (NASDAQ:NH) was last updated on 1/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.